Therapeutic Challenges in the Management of Acute Pulmonary Embolism in a Cancer Patient with Chemotherapy-induced Thrombocytopenia
  • Abuajela Sreh
    General Internal Medicine, Walsall Manor Hospital, United Kingdom http://orcid.org/0000-0002-3434-3357
  • Shailesh Nakeshree
    Geriatrics and General Internal Medicine, Walsall Manor Hospital, United Kingdom
  • Senthil-Kumar Krishnasamy
    Consultant in Diabetes and General Internal Medicine, Walsall Manor Hospital, United Kingdom
  • Nuri Alfasi
    Consultant in Haematology and General Internal Medicine, AlKhums General Hospital, Libya

Abstract

This case demonstrates the therapeutic challenges encountered when managing an acute pulmonary embolism in a cancer patient with thrombocytopenia. A 64-year-old man with a history of lung cancer receiving chemotherapy was admitted to Walsall Manor Hospital with haemodynamic instability consistent with a pulmonary embolism, proven on computed tomographic pulmonary angiogram. His platelet count was noted to be 35×109/l (chemotherapy-induced thrombocytopenia). After discussions, he was deemed not suitable for thrombolysis based on risk versus benefits. The patient was initially transfused one adult dose of platelets and treated with half the therapeutic dose of low molecular weight heparin (LMWH). The same management plan was followed until the platelet count exceeded 50×10sup>9/l, after which the patient was established on the full therapeutic dose of LMWH. Clinically, the patient improved and was discharged. Three months after discharge, follow-up revealed sustained clinical improvement while the patient continued to be on the full therapeutic dose of LMWH with a stable platelet count.

VIEW THE ENTIRE ARTICLE

References

  • - Kopolovic I, Lee A and Wu C. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study. Ann Hematol (2015) 94:329–336.
  • - Mandalà M, Falanga A and Roilaet F; on behalf of the ESMO Guidelines Working Group. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol (2011) 22 (suppl_6): vi85-vi92. Available from URL: https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdr392.
  • -Valent J and Schiffer CA. Thrombocytopenia and platelet transfusions in patients with cancer. Cancer Treat Res (2011) 157:251–265.
  • -Curtis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology (2014) 30(2):55-65.
  • - Lyman G, Khorana A, Kuderer N, Lee A, Arcelus J, Balaban E, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update. J. Clin. Oncol (2013) 31, 2189–2204.
  • - Watson H, Keeling D, Laffan M, Laffan M, Tait R, Makris M, et al. Guideline on aspects of cancer-related venous thrombosis. British Journal of Haematology (2015) 170; 640–648.
  • - Noble S, Shelley M, Coles B, Williams S, Wilcock A, Johnson M, et al. Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis. Lancet Oncol (2008); 9(6):577-84.
  • - Jaff M, McMurtry M, Archer S, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. ulation. 2011 Apr 26;123(16):1788-830. Available online from URL: http://circ.ahajournals.org/content/123/16/1788.long
  • - Carrier M, Khorana A, Zwicker JI, Noble S and Lee A. Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Thromb Haemost 2013; 11: 1760–5.
  • Views: 2963
    HTML downloads: 279
    PDF downloads: 2341


    Published: 2017-11-14
    Issue: Vol. 5 No. 1 (view)


    How to cite:
    1.
    Sreh A, Nakeshree S, Krishnasamy S-K, Alfasi N. Therapeutic Challenges in the Management of Acute Pulmonary Embolism in a Cancer Patient with Chemotherapy-induced Thrombocytopenia. EJCRIM 2017;5 doi:10.12890/2017_000713.